Koyfin Home > Directory > Health Care > Acceleron Pharma > Return on Assets %

Acceleron Pharma Return on Assets % Chart (XLRN)

Acceleron Pharma annual/quarterly Return on Assets % from 2013 to 2020.
  • Acceleron Pharma Return on Assets % for the quarter ending June 06, 2020 was -10.02 a -128.00% increase of 12.83 year over year
  • Acceleron Pharma Return on Assets % for the last 12 months ending June 06, 2020 was -17.59 a -22.33% increase of 3.93 year over year
  • Acceleron Pharma Annual Return on Assets % for 2019 was -20.81 a -6.17% increase of 1.28 from 2018
  • Acceleron Pharma Annual Return on Assets % for 2018 was -22.09 a 2.27% decrease of -0.50 from 2017
  • Acceleron Pharma Annual Return on Assets % for 2017 was -21.59 a 2.85% decrease of -0.61 from 2016
Other Margins & Efficiency Metrics:
  • Acceleron Pharma EBITDA Margin for the quarter ending March 03, 2016 was $-20m a -39.99% increase of 8m year over year
  • Acceleron Pharma Return on Capital % for the quarter ending September 09, 2018 was -23.05 a 14.16% decrease of -3.26 year over year
  • Acceleron Pharma Return on Equity % for the quarter ending September 09, 2018 was -35.54 a 13.15% decrease of -4.68 year over year
View Chart On Koyfin

Quarterly XLRN Return on Assets % Data

06/2020-10.02
03/2020-26.61
12/2019-12.48
09/2019-22.85
06/2019-9.51
03/2019-23.31
12/2018-28.18
09/2018-21.79
06/2018-20.72
03/2018-18.20

Annual XLRN Return on Assets % Data

2019-20.81
2018-22.09
2017-21.59
2016-20.97
2015-22.88
2014-20.35
20135.02
2012-29.36